{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:03:03Z","timestamp":1772823783349,"version":"3.50.1"},"reference-count":50,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities","award":["82271192"],"award-info":[{"award-number":["82271192"]}]},{"name":"National Natural Science Foundation of China","award":["82271192"],"award-info":[{"award-number":["82271192"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Amino acid metabolism has been implicated in tumorigenesis and tumor progression. Alterations in intracellular and extracellular metabolites associated with metabolic reprogramming in cancer have profound effects on gene expression, cell differentiation, and tumor immune microenvironment. However, the prognostic significance of amino acid metabolism in head and neck cancer remains to be further investigated. In this study, we identified 98 differentially expressed genes related to amino acid metabolism in head and neck cancer in The Cancer Genome Atlas. Using batch univariate Cox regression and Lasso regression, we extracted nine amino acid metabolism-related genes. Based on that, we developed the amino acid metabolism index. The prognostic value of this index was validated in two Gene Expression Omnibus cohorts. The results show that this model can help predict tumor recurrence and prognosis. The infiltration of immune cells in the tumor microenvironment was analyzed, and it was discovered that the high index is associated with an immunosuppressive microenvironment. In addition, this study demonstrated the impact of the amino acid metabolism index on clinical indicators, survival of patients with head and neck cancer, and the prediction of treatment response to immune checkpoint inhibitors. We conducted several cell experiments and demonstrated that epigenetic drugs could affect the index and enhance tumor immunity. In conclusion, our study demonstrates that the index not only has important prognostic value in head and neck cancer patients but also facilitates patient stratification for immunotherapy.<\/jats:p>","DOI":"10.3390\/ijms241411753","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:47:03Z","timestamp":1690159623000},"page":"11753","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Prognostic Model of Head and Neck Cancer Based on Amino Acid Metabolism-Related Signature and Its Implication for Immunosuppressive Microenvironment"],"prefix":"10.3390","volume":"24","author":[{"given":"Xuran","family":"Li","sequence":"first","affiliation":[{"name":"Department of ORL-HNS, Shanghai Fourth People\u2019s Hospital, School of Medicine, Tongji University, Shanghai 201804, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[{"name":"Department of ORL-HNS, Shanghai Fourth People\u2019s Hospital, School of Medicine, Tongji University, Shanghai 201804, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of ORL-HNS, Shanghai Fourth People\u2019s Hospital, School of Medicine, Tongji University, Shanghai 201804, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7973-2803","authenticated-orcid":false,"given":"Yiliang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai 201804, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai 201804, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-0163","authenticated-orcid":false,"given":"Fei","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of ORL-HNS, Shanghai Fourth People\u2019s Hospital, School of Medicine, Tongji University, Shanghai 201804, China"},{"name":"The Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland"},{"name":"The Royal College of Surgeons of England, London WC2A 3PE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2018.09.001","article-title":"Precision medicine in head and neck cancer","volume":"40","author":"Gil","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104460","DOI":"10.1016\/j.oraloncology.2019.104460","article-title":"Immunotherapy for head and neck cancer: Recent advances and future directions","volume":"99","author":"Cramer","year":"2019","journal-title":"Oral Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.celrep.2014.04.045","article-title":"Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells","volume":"7","author":"Labuschagne","year":"2014","journal-title":"Cell Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","article-title":"Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy","volume":"80","author":"Wang","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","article-title":"T cell metabolic fitness in antitumor immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101977","DOI":"10.1016\/j.ctrv.2020.101977","article-title":"Biomarkers for immunotherapy response in head and neck cancer","volume":"84","author":"Gavrielatou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.it.2019.09.008","article-title":"Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer","volume":"40","author":"Fujii","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1182\/blood.2019001034","article-title":"Amino acid metabolism in hematologic malignancies and the era of targeted therapy","volume":"134","author":"Tabe","year":"2019","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fimmu.2020.01185","article-title":"Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies","volume":"11","author":"Zhai","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The Tumor Microenvironment Innately Modulates Cancer Progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR Pathway for Cancer Immunotherapy\u2014Challenges and Opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mazzoni, A., Capone, M., and Ramazzotti, M. (2021). IL4I1 Is Expressed by Head-Neck Cancer-Derived Mesenchymal Stromal Cells and Contributes to Suppress T Cell Proliferation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102111"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3389\/fimmu.2020.01243","article-title":"Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1","volume":"11","author":"Botticelli","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: Targeting epigenetic marks in cancer treatment","volume":"14","author":"Furtado","year":"2019","journal-title":"Epigenetics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/bjc.2013.645","article-title":"Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients","volume":"109","author":"Jie","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2018.02.013","article-title":"Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment","volume":"196","author":"Ballestar","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","article-title":"Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy","volume":"29","author":"Bertero","year":"2019","journal-title":"Cell Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","article-title":"Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours","volume":"20","author":"Baudrier","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., and Chiaradonna, F. (2009). Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004715"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1080\/15548627.2019.1639302","article-title":"SLC3A2\/CD98hc, autophagy and tumor radioresistance: A link confirmed","volume":"15","author":"Digomann","year":"2019","journal-title":"Autophagy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","article-title":"The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta. Pharm. Sin. B."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2003404","DOI":"10.1002\/advs.202003404","article-title":"Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"846s","DOI":"10.1093\/jn\/131.3.846S","article-title":"Function of leucine in excitatory neurotransmitter metabolism in the central nervous system","volume":"131","author":"Hutson","year":"2001","journal-title":"J. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2017.04.023","article-title":"PLOD2 in cancer research","volume":"90","author":"Du","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/sji.12479","article-title":"Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll-like Receptor Stimulation in Peripheral Monocytes","volume":"84","author":"Orhan","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hed.24406","article-title":"Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma","volume":"38","author":"Nguyen","year":"2016","journal-title":"Head Neck"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic Regulation of Macrophage Polarization in Cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105084","DOI":"10.1016\/j.oraloncology.2020.105084","article-title":"Prognostic impact of regulatory T cell in head and neck squamous cell carcinoma: A systematic review and meta-analysis","volume":"112","author":"Cho","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10238-004-0042-3","article-title":"Non-antigen specific CD8+ T suppressor lymphocytes","volume":"4","author":"Filaci","year":"2004","journal-title":"Clin. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1196\/annals.1313.013","article-title":"Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation","volume":"1050","author":"Filaci","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1073\/pnas.1216671110","article-title":"Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8+ T cell skewing in allergic lung disease","volume":"110","author":"Jia","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"652054","DOI":"10.3389\/fimmu.2021.652054","article-title":"Immunotherapy Advances in Locally Advanced and Recurrent\/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/ijc.32024","article-title":"Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer","volume":"144","author":"Matoba","year":"2019","journal-title":"Int. J. Cancer."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","article-title":"A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer","volume":"26","author":"Rodriguez","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coph.2017.05.006","article-title":"Epigenetic modulation in cancer immunotherapy","volume":"35","author":"Gallagher","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e000957","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-020-00913-2","article-title":"CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma","volume":"13","author":"Lupo","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11753\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:16:32Z","timestamp":1760127392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":50,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241411753"],"URL":"https:\/\/doi.org\/10.3390\/ijms241411753","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}